Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Mettler-Toledo International Inc. (MTD) Stock Forecast & Price Prediction Switzerland | NYSE | Healthcare | Diagnostics & Research
$1,173.74
+5.74 (0.49%)Did MTD Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Mettler-Toledo is one of their latest high-conviction picks.
Based on our analysis of 23 Wall Street analysts, MTD has a neutral consensus with a median price target of $1,480.00 (ranging from $1,200.00 to $1,700.00). The overall analyst rating is N/A (N/A/10). Currently trading at $1,173.74, the median forecast implies a 26.1% upside. This outlook is supported by 6 Buy, 8 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Patrick Donnelly at Citigroup, projecting a 44.8% upside. Conversely, the most conservative target is provided by Brandon Couillard at Wells Fargo, suggesting a 2.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MTD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 10, 2026 | Morgan Stanley | Kallum Titchmarsh | Equal-Weight | Maintains | $1,475.00 |
| Dec 15, 2025 | Barclays | Luke Sergott | Overweight | Maintains | $1,550.00 |
| Dec 15, 2025 | Wells Fargo | Brandon Couillard | Equal-Weight | Maintains | $1,450.00 |
| Dec 9, 2025 | Goldman Sachs | Evie Koslosky | Neutral | Initiates | $1,475.00 |
| Dec 2, 2025 | Morgan Stanley | Kallum Titchmarsh | Equal-Weight | Initiates | $1,550.00 |
| Nov 10, 2025 | Wells Fargo | Brandon Couillard | Equal-Weight | Maintains | $1,400.00 |
| Nov 10, 2025 | Barclays | Luke Sergott | Overweight | Maintains | $1,600.00 |
| Nov 10, 2025 | Citigroup | Patrick Donnelly | Buy | Maintains | $1,700.00 |
| Nov 10, 2025 | Stifel | Daniel Arias | Buy | Maintains | $1,600.00 |
| Oct 9, 2025 | JP Morgan | Casey Woodring | Neutral | Maintains | $1,285.00 |
| Oct 7, 2025 | Evercore ISI Group | Vijay Kumar | Outperform | Maintains | $1,400.00 |
| Oct 2, 2025 | Barclays | Luke Sergott | Overweight | Maintains | $1,350.00 |
| Sep 22, 2025 | B of A Securities | Derik De Bruin | Neutral | Maintains | $1,390.00 |
| Aug 21, 2025 | Citigroup | Patrick Donnelly | Buy | Maintains | $1,600.00 |
| Aug 4, 2025 | Evercore ISI Group | Vijay Kumar | Outperform | Maintains | $1,275.00 |
| Aug 4, 2025 | Baird | Catherine Schulte | Neutral | Maintains | $1,230.00 |
| Jul 28, 2025 | Baird | Catherine Schulte | Neutral | Maintains | $1,210.00 |
| Jul 8, 2025 | Evercore ISI Group | Vijay Kumar | Outperform | Maintains | $1,280.00 |
| Jun 26, 2025 | B of A Securities | Derik De Bruin | Neutral | Maintains | $1,260.00 |
| Jun 24, 2025 | Barclays | Luke Sergott | Overweight | Initiates | $1,325.00 |
The following stocks are similar to Mettler-Toledo based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Mettler-Toledo International Inc. has a market capitalization of $23.98B with a P/E ratio of 27.8x. The company generates $4.03B in trailing twelve-month revenue with a 21.6% profit margin.
Revenue growth is +8.1% quarter-over-quarter, while maintaining an operating margin of +30.7% and return on equity of -3,677.4%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Manufactures precision instruments for various industries.
The company generates revenue by selling precision instruments and solutions tailored for laboratory, industrial, product inspection, and food retail applications. Their comprehensive offerings include hardware and proprietary software that enhance measurement accuracy and operational efficiency, catering to sectors such as life sciences, pharmaceuticals, and logistics.
Mettler-Toledo employs approximately 17,300 people and operates in around 40 countries, providing a strong sales and service network that fosters customer support and retention. The companyโs commitment to precision and innovation positions it as a crucial partner in ensuring quality standards across diverse industries.
Healthcare
Diagnostics & Research
16,600
Mr. Patrick K. Kaltenbach
Switzerland
1997
Mettler-Toledo (MTD) is technically oversold, suggesting reduced selling pressure. Analysts are revising earnings estimates higher, indicating a potential trend reversal.
Mettler-Toledo's oversold status suggests reduced selling pressure, while revised earnings estimates from analysts point to a potential stock rebound, signaling a buying opportunity.
Arch Capital Group shares rose on strong earnings; IDEXX Laboratories outperformed expectations. Kinsale Capital Group shares fell due to growth concerns in the property and casualty insurance sector.
Arch Capital's strong earnings and capital management boost investor confidence, while IDEXX's better-than-expected results highlight resilience. Kinsale's decline signals caution in the insurance sector.
HSY, MCO, CBRE, MTD, and ZBRA are identified as wide-moat leaders with strong growth prospects and increasing estimates, suitable for enhancing portfolio stability and returns.
The mention of HSY, MCO, CBRE, MTD, and ZBRA as wide-moat leaders indicates strong competitive advantages, suggesting potential for stable returns and growth in investor portfolios.
Mettler-Toledo International Inc. (MTD) held its Q4 2025 earnings call, providing insights into financial performance and future outlook. Details of the call are available in the transcript.
Mettler-Toledo's Q4 earnings call provides insights into its financial performance, growth prospects, and market conditions, influencing investor sentiment and stock valuation.
MTD exceeded Q4 estimates with an 8% year-over-year increase in adjusted EPS and sales reaching $1.13B, driven by strong growth in Laboratory, Industrial, and Food Retail sectors.
MTD's Q4 performance surpassing estimates and strong sales growth signals robust demand and operational efficiency, potentially boosting investor confidence and stock value.
Mettler-Toledo (MTD) reports revenue and EPS for Q4 2025, suggesting a comparison with Wall Street estimates and prior year metrics may be important for investors.
Mettler-Toledo's revenue and EPS performance relative to Wall Street estimates and previous year figures reveal trends that can impact stock valuation and future investor sentiment.
Based on our analysis of 23 Wall Street analysts, Mettler-Toledo International Inc. (MTD) has a median price target of $1,480.00. The highest price target is $1,700.00 and the lowest is $1,200.00.
According to current analyst ratings, MTD has 6 Buy ratings, 8 Hold ratings, and 1 Sell ratings. The stock is currently trading at $1,173.74. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict MTD stock could reach $1,480.00 in the next 12 months. This represents a 26.1% increase from the current price of $1,173.74. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by selling precision instruments and solutions tailored for laboratory, industrial, product inspection, and food retail applications. Their comprehensive offerings include hardware and proprietary software that enhance measurement accuracy and operational efficiency, catering to sectors such as life sciences, pharmaceuticals, and logistics.
The highest price target for MTD is $1,700.00 from Patrick Donnelly at Citigroup, which represents a 44.8% increase from the current price of $1,173.74.
The lowest price target for MTD is $1,200.00 from Brandon Couillard at Wells Fargo, which represents a 2.2% increase from the current price of $1,173.74.
The overall analyst consensus for MTD is neutral. Out of 23 Wall Street analysts, 6 rate it as Buy, 8 as Hold, and 1 as Sell, with a median price target of $1,480.00.
Stock price projections, including those for Mettler-Toledo International Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.